Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
17.15
-14.06
-81.98%
Share Warrants & Outstandings
Total Reserve
68.71
52.23
16.48
31.55%
Shareholder's Funds
71.80
69.38
2.42
3.49%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
18.38
-18.38
-100.00%
Secured Loans
0.00
13.60
-13.60
-100.00%
Unsecured Loans
0.00
4.78
-4.78
-100.00%
Deferred Tax Assets / Liabilities
0.11
-0.01
0.12
1,200.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.11
12.78
-12.67
-99.14%
Current Liabilities
Trade Payables
38.70
40.18
-1.48
-3.68%
Other Current Liabilities
0.94
3.35
-2.41
-71.94%
Short Term Borrowings
9.91
35.77
-25.86
-72.30%
Short Term Provisions
0.02
0.00
0.02
0.00%
Total Current Liabilities
49.58
79.30
-29.72
-37.48%
Total Liabilities
121.49
161.47
-39.98
-24.76%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
52.18
-35.33
-67.71%
Less: Accumulated Depreciation
6.37
11.92
-5.55
-46.56%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
40.26
-29.78
-73.97%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
3.10
-3.10
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
0.00
0.75
0.00%
Other Non Current Assets
3.46
2.93
0.53
18.09%
Total Non-Current Assets
18.13
46.29
-28.16
-60.83%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
39.61
-1.60
-4.04%
Sundry Debtors
56.54
60.58
-4.04
-6.67%
Cash and Bank
0.16
0.26
-0.10
-38.46%
Other Current Assets
0.17
2.70
-2.53
-93.70%
Short Term Loans and Advances
8.13
12.03
-3.90
-32.42%
Total Current Assets
103.36
115.18
-11.82
-10.26%
Net Current Assets (Including Current Investments)
53.78
35.87
17.91
49.93%
Total Current Assets Excluding Current Investments
103.00
115.18
-12.18
-10.57%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
161.47
-39.98
-24.76%
Contingent Liabilities
0.00
12.82
-12.82
-100.00%
Total Debt
9.91
42.99
-33.08
-76.95%
Book Value per share (adjusted)
232.39
40.46
191.93
474.37%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
